Should upper gastrointestinal endoscopy be systematically performed in patients with Inflammatory Bowel Disease ?
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S402
DOI: 10.1055/s-0044-1783700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von H. Koulali und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Understanding the extent of Inflammatory Bowel Disease (IBD) is fundamental for optimal management, while Crohn's disease (CD) can affect all the gastro-intestinal tract, ulcerative colitis is localized in the rectum and colon. This study investigates the potential utility of systemic gastroscopy in IBD patients.
Methods
Utilizing data from our gastroenterology department, we performed a retrospective cohort study. encompassed patients diagnosed with IBD who underwent systematic upper gastrointestinal endoscopy (UGE). Clinical, endoscopic, and histopathological data were gathered and analyzed.
Results
A total of 141 individuals diagnosed with Crohn's disease (CD) and 61 with ulcerative colitis (UC) were part of this study. The average age was 40.7 years, and there was a female-to-male ratio of 1.33. Notably, 95.5% of these patients reported no upper gastrointestinal symptoms prior to upper gastrointestinal endoscopy (UGE). For those with symptoms, dyspepsia and pyrosis were the most reported. Results showed that 73.9% of patients without symptoms had a normal mucosa during UGE, in the other cases, the following abnormalities were observed: non-specific gastro-duodenal erosions and ulcerations (8.5%), mild esophagitis (4%), aphthoid ulcerations (2%), and duodenal stenosis (0.5%). In symptomatic patients, UGE findings varied, ranging from normal results in 4 cases to atrophy of the fundus mucosa in 1 case, esophageal hernia in 2 cases, and esophageal aphthoid ulcerations in 1 case. Systematic gastro-duodenal biopsies showed: lymphoplasmacytic infiltrate (47.7%) and Helicobacter pylori (HP) presence (38.1%) in asymptomatic patients, while in symptomatic patients, fundic metaplasia (0.5%), lymphoplasmacytic infiltrate (2.5%), HP presence (2.4%), duodenal villi atrophy (0.5%), and glandular atrophy (0.5%) were observed. The study's analysis didn't establish significant associations between endoscopic lesions and UC (p=0.36) or CD (p=0.09), however, a notable association was found between male gender and the presence of endoscopic lesions (p=0.033).
Conclusions
Even though patients with IBD might not show any symptoms, conducting UGE and histopathological examinations could uncover upper gastrointestinal lesions. These findings significantly contribute to the comprehensive assessment and management of IBD. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Koulali, H., Zazour, A., Elmqaddem, O., Ismaili, Z., & Ghizlane, K. (2024). Should upper gastrointestinal endoscopy be systematically performed in patients with Inflammatory Bowel Disease ?. Endoscopy, 56(S 02 S 02), S402. https://doi.org/10.1055/s-0044-1783700
Vancouver
Koulali H, Zazour A, Elmqaddem O, Ismaili Z, Ghizlane K. Should upper gastrointestinal endoscopy be systematically performed in patients with Inflammatory Bowel Disease ?. Endoscopy. 2024;56(S 02 S 02):S402. doi:10.1055/s-0044-1783700
BibTeX
@article{Koulali2024,
author = {Koulali, H. and Zazour, A. and Elmqaddem, O. and Ismaili, Z. and Ghizlane, K.},
title = {Should upper gastrointestinal endoscopy be systematically performed in patients with Inflammatory Bowel Disease ?},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S402},
doi = {10.1055/s-0044-1783700}
}
EUVIMED